Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias [Phase 2]
An update on a Phase 2 clinical trial evaluating botulinum toxin injections to prevent secondary atrial fibrillation in patients with suprav…
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies (RAMSES)
A completed real-world, multicentre observational study evaluating stroke prevention strategies in people with thrombotic stroke and atrial …
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Rate Ventricular Control Therapy in Patients With Permanent Atrial Fibrillation [Phase 3]
A Phase 3 clinical trial update for rate ventricular control therapy in patients with permanent atrial fibrillation; the study status is unk…
-
CLINICAL_TRIALS trial_result · 2015-09-16Clinical Trial Update: Evaluation Of New Onset Postoperative Atrial Fibrillation [NA]
Clinical trial update for a study on new onset postoperative atrial fibrillation with results posted in 2015.
-
CLINICAL_TRIALS research · 2015-09-09Clinical Trial Update: Pleotropic Effect of New Oral Anticoagulants [Phase 3]
A Phase 3 clinical trial update examines the pleiotropic effects of new oral anticoagulants in patients with atrial fibrillation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: Effectiveness Study of Atrial Fibrillation
The document reports the completion of an effectiveness study for atrial fibrillation, but no efficacy results are provided in the snippet.
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: High Sensitivity Cardiac Troponin T in Patients With Atrial Fibrillation Admitted to an Emergency Department (ED)
A completed clinical trial evaluating high-sensitivity cardiac troponin T in patients with atrial fibrillation admitted to the emergency dep…
-
FDA approval · 2015-09-03FDA Approved: LANOXIN — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA approved a supplemental application for Lanoxin (digoxin) from Advanz Pharma US Corp., associated with NDA 020405. The supplement ma…
-
CLINICAL_TRIALS research · 2015-09-02Clinical Trial Update: SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)
A clinical trial update for the SAMURAI-NVAF study on anticoagulant therapy for Japanese stroke patients with nonvalvular atrial fibrillatio…
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Bioequivalence Study of Rivaroxaban [Phase 1]
A Phase 1 bioequivalence study of rivaroxaban conducted by Bayer has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male Subjects [Phase 1]
Phase 1 bioequivalence study of rivaroxaban in healthy Japanese adult male subjects has completed. Sponsored by Bayer.
-
CLINICAL_TRIALS trial_result · 2015-08-31Clinical Trial Update: Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) [NA]
Clinical trial WARFARIN investigates pharmacogenetic testing at warfarin initiation to reduce adverse events in adults. The study status is …
-
FDA approval · 2015-08-27FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved Strides Pharma Science Limited's supplemental application for propafenone hydrochloride, enabling a generic version of this…
-
FDA approval · 2015-08-25FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approves Apotex Corp.'s supplemental application for diltiazem hydrochloride (generic) under an abbreviated new drug application (ANDA).
-
FDA approval · 2015-08-25FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Sotalol hydrochloride from Aurobindo Pharma Limited. The approval confirms the generic product's…
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: Eagle AF (Atrial Fibrillation) - Endoscopically Guided Laser Ablation of Persistent Atrial Fibrillation [NA]
A clinical trial evaluating endoscopically guided laser ablation for persistent atrial fibrillation is described. No status information is p…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Cerebral Oxygen Saturation Measurement During Cardioversion Because of Atrial Fibrillation [NA]
The completed clinical trial evaluated cerebral oxygen saturation during electrical and pharmacological cardioversion in patients with atria…
-
CLINICAL_TRIALS trial_result · 2015-08-14Clinical Trial Update: Relationship Between Autonomic Central Nervous System Activation and Atrial Fibrillation Using Functional MRI (fMRI)
A completed clinical trial study evaluating the relationship between autonomic central nervous system activation and atrial fibrillation usi…
-
FDA approval · 2015-08-13FDA Approved: PACERONE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for PACERONE (amiodarone hydrochloride) from Upsher-Smith Laboratories.
-
FDA approval · 2015-08-13FDA Approved: PROPAFENONE HCL — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Propafenone hydrochloride (Propafenone HCl) from Actavis Pharma, Inc.
-
CLINICAL_TRIALS research · 2015-08-13Clinical Trial Update: High Sensitivity Troponin T Levels Following DC Cardioversion for Atrial Fibrillation / Atrial Flutter
This completed study evaluates high-sensitivity troponin T levels after direct current cardioversion in patients with atrial fibrillation or…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Safety and Performance Study to Evaluate Access to Pulmonary Veins for Treatment of Paroxysmal AF [NA]
A completed safety and performance study evaluating access to the pulmonary veins for treating paroxysmal atrial fibrillation, sponsored by …
-
CLINICAL_TRIALS trial_result · 2015-08-06Clinical Trial Update: Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran [Phase 4]
This Phase 4 clinical trial compares the anti-inflammatory effects of rivaroxaban versus dabigatran in patients with atrial fibrillation. Th…
-
FDA approval · 2015-07-28FDA Approved: DIGOXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Digoxin from Hikma Pharmaceuticals USA Inc. for continued marketing of the drug and potential la…
-
FDA approval · 2015-07-28FDA Approved: LANOXIN — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approves a supplemental application for LANOXIN (digoxin) from Advanz Pharma (US) Corp., under the supplemental NDA framework.